How has been the historical performance of GPT Healthcare?

Answer:The historical performance of GPT Healthcare shows significant growth in various financial metrics from March 2021 to March 2022.

Breakdown:
In the fiscal year ending March 2022, GPT Healthcare reported net sales of 337.42 Cr, an increase from 242.75 Cr in the previous year. Total operating income mirrored this growth, reaching 337.42 Cr compared to 242.75 Cr in March 2021. The total expenditure, excluding depreciation, rose to 263.58 Cr from 193.76 Cr, leading to an operating profit (PBDIT) of 78.83 Cr, up from 55.10 Cr. Profit before tax also saw a substantial increase to 54.08 Cr from 28.88 Cr, resulting in a profit after tax of 41.66 Cr, compared to 21.09 Cr the prior year. The earnings per share improved to 5.22 from 3.92, and the PAT margin increased to 12.35% from 8.69%. On the balance sheet, total liabilities grew to 319.51 Cr from 310.61 Cr, while total assets increased to the same figure, indicating stability. Cash flow from operating activities rose to 65.00 Cr from 42.00 Cr, contributing to a closing cash and cash equivalent of 8.00 Cr, up from 4.00 Cr. Overall, GPT Healthcare demonstrated a robust financial performance with notable increases in sales, profits, and cash flow.